112 related articles for article (PubMed ID: 38321568)
1. DNMT3A
Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
[TBL] [Abstract][Full Text] [Related]
3. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
[TBL] [Abstract][Full Text] [Related]
4. Angioimmunoblastic T-cell lymphoma involving the nasopharynx: An easily misdiagnosed disease with atypical histopathological features.
Xu T; Zhang X; Zhu J; Huang C; Zhou M; Hu L; Guo L; Lin S; Lin X; Zang S
Hum Pathol; 2024 Mar; 145():86-94. PubMed ID: 38431056
[TBL] [Abstract][Full Text] [Related]
5. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
Chavez JC; Foss FM; William BM; Brammer JE; Smith SM; Prica A; Zain JM; Tuscano JM; Shah H; Mehta-Shah N; Geethakumari PR; Wang BX; Zantinge S; Wang L; Zhang L; Boutrin A; Zhao W; Cheng L; Standifer N; Hewitt L; Enowtambong E; Shao W; Sharma S; Carlesso G; Moscow JA; Siu LL
Clin Cancer Res; 2023 May; 29(10):1869-1878. PubMed ID: 36826995
[TBL] [Abstract][Full Text] [Related]
7. Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.
Zhang Q; Yin L; Lai Q; Zhao Y; Peng H
Clin Exp Med; 2023 Dec; 23(8):4219-4235. PubMed ID: 37759042
[TBL] [Abstract][Full Text] [Related]
8. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract][Full Text] [Related]
9. New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.
Mhaidly R; Krug A; Gaulard P; Lemonnier F; Ricci JE; Verhoeyen E
Oncogenesis; 2020 Aug; 9(8):73. PubMed ID: 32796826
[TBL] [Abstract][Full Text] [Related]
10. The relationship and clinical significance of serum cytokine expression level and skin pruritus in patients with Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma.
Wen X; Yu H; Zhang L; Li L; Wang X; Fu X; Sun Z; Zhang X; Zhu L; Wu X; Yan J; Shi C; Zhang M; Zhang M; Li X
Int Immunopharmacol; 2024 Apr; 131():111777. PubMed ID: 38489975
[TBL] [Abstract][Full Text] [Related]
11. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
Arlauckas SP; Popov AV; Delikatny EJ
Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
[TBL] [Abstract][Full Text] [Related]
12. Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review.
Iturrate I; Loscertales J; Fernández-Ruiz E; Muñoz P; López C; Del Campo L; Muñoz C; Alegre A
Clin Case Rep; 2020 Dec; 8(12):3494-3497. PubMed ID: 33363958
[TBL] [Abstract][Full Text] [Related]
13. EDI3, a key enzyme of choline metabolism controls tumour cell migration.
Marchan R; Stewart JD; Lesjak M
EXCLI J; 2012; 11():260-2. PubMed ID: 27231468
[No Abstract] [Full Text] [Related]
14. Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.
Krug A; Tosolini M; Madji Hounoum B; Fournié JJ; Geiger R; Pecoraro M; Emond P; Gaulard P; Lemonnier F; Ricci JE; Verhoeyen E
J Exp Clin Cancer Res; 2024 Feb; 43(1):43. PubMed ID: 38321568
[TBL] [Abstract][Full Text] [Related]
15. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
16. GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.
Mondragón L; Mhaidly R; De Donatis GM; Tosolini M; Dao P; Martin AR; Pons C; Chiche J; Jacquin M; Imbert V; Proïcs E; Boyer L; Doye A; Luciano F; Neels JG; Coutant F; Fabien N; Sormani L; Rubio-Patiño C; Bossowski JP; Muller F; Marchetti S; Villa E; Peyron JF; Gaulard P; Lemonnier F; Asnafi V; Genestier L; Benhida R; Fournié JJ; Passeron T; Ricci JE; Verhoeyen E
Cancer Cell; 2019 Sep; 36(3):268-287.e10. PubMed ID: 31447347
[TBL] [Abstract][Full Text] [Related]
17. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
Fujisawa M; Chiba S; Sakata-Yanagimoto M
J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
[TBL] [Abstract][Full Text] [Related]
19. Advances in understanding of angioimmunoblastic T-cell lymphoma.
Chiba S; Sakata-Yanagimoto M
Leukemia; 2020 Oct; 34(10):2592-2606. PubMed ID: 32704161
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]